‌Barry Reisberg

Active 1979–2023

Also published as
Barry Reisberg
90
Papers
34,428
Citations
79
h-index
89
i10-index

Citations

Citations per year for ‌Barry Reisberg1957: 2 citations1980: 2 citations1981: 2 citations1982: 13 citations1983: 16 citations1984: 20 citations1985: 13 citations1986: 35 citations1987: 21 citations1988: 35 citations1989: 18 citations1990: 40 citations1991: 30 citations1992: 60 citations1993: 44 citations1994: 44 citations1995: 53 citations1996: 78 citations1997: 112 citations1998: 77 citations1999: 141 citations2000: 155 citations2001: 155 citations2002: 183 citations2003: 189 citations2004: 242 citations2005: 268 citations2006: 353 citations2007: 430 citations2008: 446 citations2009: 371 citations2010: 375 citations2011: 307 citations2012: 314 citations2013: 311 citations2014: 321 citations2015: 291 citations2016: 254 citations2017: 319 citations2018: 256 citations2019: 883 citations2020: 892 citations2021: 857 citations2022: 600 citations2023: 380 citations2024: 663 citations2025: 303 citations2026: 15 citations1958–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,510 citing papers, 26.9% of this breakdownUnited Kingdom: 1,140 citing papers, 8.7% of this breakdownChina: 812 citing papers, 6.2% of this breakdownGermany: 725 citing papers, 5.6% of this breakdownCanada: 655 citing papers, 5% of this breakdownItaly: 590 citing papers, 4.5% of this breakdownSpain: 589 citing papers, 4.5% of this breakdownNetherlands: 550 citing papers, 4.2% of this breakdownAustralia: 462 citing papers, 3.5% of this breakdownFrance: 401 citing papers, 3.1% of this breakdownSweden: 399 citing papers, 3.1% of this breakdownJapan: 270 citing papers, 2.1% of this breakdown
0%26.9%Other 22.6%

Fields

  • Medicine66.9%
  • Neuroscience15.4%
  • Biochemistry, Genetics and Molecular Biology4.5%
  • Psychology3.5%
  • Health Professions3.2%
  • Computer Science2.5%
  • Other4%

Topics

  • Dementia and Cognitive Impairment Research18.1%
  • Alzheimer's disease research and treatments10%
  • Functional Brain Connectivity Studies3.9%
  • Neurological Disease Mechanisms and Treatments2.3%
  • Cholinesterase and Neurodegenerative Diseases1.8%
  • Advanced Neuroimaging Techniques and Applications1.6%
  • Other62.3%

Coauthors

All papers

Open in search
  1. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Reisa A. Sperling, Robert Stewart, Olga Uspenskaya, Bruno Vellas, Pieter Jelle Visser, Michael Wagner, Subjective Cognitive Decline Initiative (SCD‐I) Working Group - Alzheimer s & Dementia 2014 cited by 3,044

  2. Mild cognitive impairment

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2006 cited by 3,865

  3. The Global Deterioration Scale for assessment of primary degenerative dementia

    Authors: , , , - American Journal of Psychiatry 1982 cited by 5,012

  4. Memantine in Moderate-to-Severe Alzheimer's Disease

    Authors: , , , , , - New England Journal of Medicine 2003 cited by 2,019

  5. Implementation of subjective cognitive decline criteria in research studies

    Authors: , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2016 cited by 587

  6. Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , the Alzheimer's Disease Neuroimaging Initiative, the DESCRIPA working group, the INSIGHT‐preAD study group, SCD‐I working group, Wiesje M. van der Flier - Alzheimer s & Dementia 2018 cited by 457

  7. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease

    Authors: , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2009 cited by 477

  8. Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy

    Authors: , , , , , , , , , , , , , , , , , , , , , - Dementia and Geriatric Cognitive Disorders 2010 cited by 925

  9. Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew J. Saykin, Melissa J. Slavin, Beth E. Snitz, Reisa A. Sperling, Caroline Tandetnik, Wiesje M. van der Flier, Michael Wagner, Steffen Wolfsgruber, Sietske A.M. Sikkes - Journal of Alzheimer s Disease 2015 cited by 469

  10. Functional Assessment Staging (FAST)

    Authors: - Management of Dementia 2001 cited by 1,032

  11. Functional Assessment Staging (FAST) in Alzheimer’s Disease: Reliability, Validity, and Ordinality

    Authors: , - International Psychogeriatrics 1992 cited by 602

  12. Outcome over seven years of healthy adults with and without subjective cognitive impairment

    Authors: , , , , - Alzheimer s & Dementia 2010 cited by 576

  13. Mild cognitive impairment in the elderly

    Authors: , , - Neurology 1991 cited by 835

  14. Prediction of cognitive decline in normal elderly subjects with 2-[ 18 F]fluoro-2-deoxy- d -glucose/positron-emission tomography (FDG/PET)

    Authors: , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 631

  15. The pre–mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease

    Authors: , , , , , , , , , , , - Alzheimer s & Dementia 2008 cited by 313

  16. Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of Change

    Authors: , , , , , , , , , - Alzheimer Disease & Associated Disorders 1997 cited by 652

  17. Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease

    Authors: , - International Psychogeriatrics 2007 cited by 340

  18. Vascular Cognitive Impairment

    Authors: , , , , , , , , , , , , , - International Journal of Stroke 2003 cited by 1,169

  19. Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging

    Authors: , , , , , , , - Neurobiology of Aging 2005 cited by 283

  20. The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome

    Authors: , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2008 cited by 111

  21. Cortical myelin profile variations in healthy aging brain: A T1w/T2w ratio study

    Authors: , , , , - NeuroImage 2022 cited by 26

  22. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.

    Authors: , , , , , - 1987 cited by 1,114

  23. Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease

    Authors: , , , , , , , , , , , , , , - Neurology 2004 cited by 293

  24. MRI and CSF studies in the early diagnosis of Alzheimer's disease

    Authors: , , , , , , , , , , , , , - Journal of Internal Medicine 2004 cited by 219